Medical Care
Global Biopharmaceutical and Vaccine Production Market Research Report 2025
- Sep 18, 25
- ID: 507947
- Pages: 81
- Figures: 85
- Views: 23
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical and Vaccine Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical and Vaccine Production.
The Biopharmaceutical and Vaccine Production market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical and Vaccine Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical and Vaccine Production companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Sanofi
Roche
Abbott
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
FUJIFILM Diosynth Biotechnologies
Segment by Type
Biopharmaceutical
Vaccine Production
Segment by Application
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical and Vaccine Production company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Biopharmaceutical and Vaccine Production market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biopharmaceutical and Vaccine Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharmaceutical and Vaccine Production companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Sanofi
Roche
Abbott
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
FUJIFILM Diosynth Biotechnologies
Segment by Type
Biopharmaceutical
Vaccine Production
Segment by Application
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical and Vaccine Production company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biopharmaceutical
1.2.3 Vaccine Production
1.3 Market by Application
1.3.1 Global Biopharmaceutical and Vaccine Production Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical and Vaccine Production Market Perspective (2020-2031)
2.2 Global Biopharmaceutical and Vaccine Production Growth Trends by Region
2.2.1 Global Biopharmaceutical and Vaccine Production Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biopharmaceutical and Vaccine Production Historic Market Size by Region (2020-2025)
2.2.3 Biopharmaceutical and Vaccine Production Forecasted Market Size by Region (2026-2031)
2.3 Biopharmaceutical and Vaccine Production Market Dynamics
2.3.1 Biopharmaceutical and Vaccine Production Industry Trends
2.3.2 Biopharmaceutical and Vaccine Production Market Drivers
2.3.3 Biopharmaceutical and Vaccine Production Market Challenges
2.3.4 Biopharmaceutical and Vaccine Production Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical and Vaccine Production Players by Revenue
3.1.1 Global Top Biopharmaceutical and Vaccine Production Players by Revenue (2020-2025)
3.1.2 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Players (2020-2025)
3.2 Global Biopharmaceutical and Vaccine Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biopharmaceutical and Vaccine Production Revenue
3.4 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio
3.4.1 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccine Production Revenue in 2024
3.5 Global Key Players of Biopharmaceutical and Vaccine Production Head office and Area Served
3.6 Global Key Players of Biopharmaceutical and Vaccine Production, Product and Application
3.7 Global Key Players of Biopharmaceutical and Vaccine Production, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical and Vaccine Production Breakdown Data by Type
4.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Type (2020-2025)
4.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2026-2031)
5 Biopharmaceutical and Vaccine Production Breakdown Data by Application
5.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Application (2020-2025)
5.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biopharmaceutical and Vaccine Production Market Size (2020-2031)
6.2 North America Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025)
6.4 North America Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical and Vaccine Production Market Size (2020-2031)
7.2 Europe Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025)
7.4 Europe Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size (2020-2031)
8.2 Asia-Pacific Biopharmaceutical and Vaccine Production Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2020-2025)
8.4 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical and Vaccine Production Market Size (2020-2031)
9.2 Latin America Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025)
9.4 Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size (2020-2031)
10.2 Middle East & Africa Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025)
10.4 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Biopharmaceutical and Vaccine Production Introduction
11.1.4 Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Biopharmaceutical and Vaccine Production Introduction
11.2.4 Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Biopharmaceutical and Vaccine Production Introduction
11.3.4 Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Biopharmaceutical and Vaccine Production Introduction
11.4.4 Roche Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Biopharmaceutical and Vaccine Production Introduction
11.5.4 Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.6.5 Regeneron Pharmaceuticals Recent Development
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Details
11.7.2 Alexion Pharmaceuticals Business Overview
11.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction
11.7.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.7.5 Alexion Pharmaceuticals Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Introduction
11.8.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.8.5 Johnson and Johnson Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Introduction
11.9.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.9.5 GlaxoSmithKline Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biopharmaceutical and Vaccine Production Introduction
11.10.4 Merck Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.10.5 Merck Recent Development
11.11 Lonza
11.11.1 Lonza Company Details
11.11.2 Lonza Business Overview
11.11.3 Lonza Biopharmaceutical and Vaccine Production Introduction
11.11.4 Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.11.5 Lonza Recent Development
11.12 FUJIFILM Diosynth Biotechnologies
11.12.1 FUJIFILM Diosynth Biotechnologies Company Details
11.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Introduction
11.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.12.5 FUJIFILM Diosynth Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biopharmaceutical
1.2.3 Vaccine Production
1.3 Market by Application
1.3.1 Global Biopharmaceutical and Vaccine Production Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical and Vaccine Production Market Perspective (2020-2031)
2.2 Global Biopharmaceutical and Vaccine Production Growth Trends by Region
2.2.1 Global Biopharmaceutical and Vaccine Production Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biopharmaceutical and Vaccine Production Historic Market Size by Region (2020-2025)
2.2.3 Biopharmaceutical and Vaccine Production Forecasted Market Size by Region (2026-2031)
2.3 Biopharmaceutical and Vaccine Production Market Dynamics
2.3.1 Biopharmaceutical and Vaccine Production Industry Trends
2.3.2 Biopharmaceutical and Vaccine Production Market Drivers
2.3.3 Biopharmaceutical and Vaccine Production Market Challenges
2.3.4 Biopharmaceutical and Vaccine Production Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical and Vaccine Production Players by Revenue
3.1.1 Global Top Biopharmaceutical and Vaccine Production Players by Revenue (2020-2025)
3.1.2 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Players (2020-2025)
3.2 Global Biopharmaceutical and Vaccine Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biopharmaceutical and Vaccine Production Revenue
3.4 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio
3.4.1 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccine Production Revenue in 2024
3.5 Global Key Players of Biopharmaceutical and Vaccine Production Head office and Area Served
3.6 Global Key Players of Biopharmaceutical and Vaccine Production, Product and Application
3.7 Global Key Players of Biopharmaceutical and Vaccine Production, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical and Vaccine Production Breakdown Data by Type
4.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Type (2020-2025)
4.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2026-2031)
5 Biopharmaceutical and Vaccine Production Breakdown Data by Application
5.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Application (2020-2025)
5.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biopharmaceutical and Vaccine Production Market Size (2020-2031)
6.2 North America Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025)
6.4 North America Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biopharmaceutical and Vaccine Production Market Size (2020-2031)
7.2 Europe Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025)
7.4 Europe Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size (2020-2031)
8.2 Asia-Pacific Biopharmaceutical and Vaccine Production Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2020-2025)
8.4 Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biopharmaceutical and Vaccine Production Market Size (2020-2031)
9.2 Latin America Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025)
9.4 Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size (2020-2031)
10.2 Middle East & Africa Biopharmaceutical and Vaccine Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025)
10.4 Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Biopharmaceutical and Vaccine Production Introduction
11.1.4 Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Biopharmaceutical and Vaccine Production Introduction
11.2.4 Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Biopharmaceutical and Vaccine Production Introduction
11.3.4 Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.3.5 Sanofi Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Biopharmaceutical and Vaccine Production Introduction
11.4.4 Roche Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Biopharmaceutical and Vaccine Production Introduction
11.5.4 Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.6.5 Regeneron Pharmaceuticals Recent Development
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Details
11.7.2 Alexion Pharmaceuticals Business Overview
11.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction
11.7.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.7.5 Alexion Pharmaceuticals Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Introduction
11.8.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.8.5 Johnson and Johnson Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Introduction
11.9.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.9.5 GlaxoSmithKline Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biopharmaceutical and Vaccine Production Introduction
11.10.4 Merck Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.10.5 Merck Recent Development
11.11 Lonza
11.11.1 Lonza Company Details
11.11.2 Lonza Business Overview
11.11.3 Lonza Biopharmaceutical and Vaccine Production Introduction
11.11.4 Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.11.5 Lonza Recent Development
11.12 FUJIFILM Diosynth Biotechnologies
11.12.1 FUJIFILM Diosynth Biotechnologies Company Details
11.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Introduction
11.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025)
11.12.5 FUJIFILM Diosynth Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biopharmaceutical
Table 3. Key Players of Vaccine Production
Table 4. Global Biopharmaceutical and Vaccine Production Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Biopharmaceutical and Vaccine Production Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Biopharmaceutical and Vaccine Production Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Biopharmaceutical and Vaccine Production Market Share by Region (2020-2025)
Table 8. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Biopharmaceutical and Vaccine Production Market Share by Region (2026-2031)
Table 10. Biopharmaceutical and Vaccine Production Market Trends
Table 11. Biopharmaceutical and Vaccine Production Market Drivers
Table 12. Biopharmaceutical and Vaccine Production Market Challenges
Table 13. Biopharmaceutical and Vaccine Production Market Restraints
Table 14. Global Biopharmaceutical and Vaccine Production Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Biopharmaceutical and Vaccine Production Market Share by Players (2020-2025)
Table 16. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2024)
Table 17. Ranking of Global Top Biopharmaceutical and Vaccine Production Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Biopharmaceutical and Vaccine Production Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Biopharmaceutical and Vaccine Production, Headquarters and Area Served
Table 20. Global Key Players of Biopharmaceutical and Vaccine Production, Product and Application
Table 21. Global Key Players of Biopharmaceutical and Vaccine Production, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biopharmaceutical and Vaccine Production Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2020-2025)
Table 25. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2026-2031)
Table 27. Global Biopharmaceutical and Vaccine Production Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2020-2025)
Table 29. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2026-2031)
Table 31. North America Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis Biopharmaceutical and Vaccine Production Product
Table 49. Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Pfizer Company Details
Table 52. Pfizer Business Overview
Table 53. Pfizer Biopharmaceutical and Vaccine Production Product
Table 54. Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Sanofi Company Details
Table 57. Sanofi Business Overview
Table 58. Sanofi Biopharmaceutical and Vaccine Production Product
Table 59. Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Biopharmaceutical and Vaccine Production Product
Table 64. Roche Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Biopharmaceutical and Vaccine Production Product
Table 69. Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Regeneron Pharmaceuticals Company Details
Table 72. Regeneron Pharmaceuticals Business Overview
Table 73. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product
Table 74. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 75. Regeneron Pharmaceuticals Recent Development
Table 76. Alexion Pharmaceuticals Company Details
Table 77. Alexion Pharmaceuticals Business Overview
Table 78. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product
Table 79. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 80. Alexion Pharmaceuticals Recent Development
Table 81. Johnson and Johnson Company Details
Table 82. Johnson and Johnson Business Overview
Table 83. Johnson and Johnson Biopharmaceutical and Vaccine Production Product
Table 84. Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 85. Johnson and Johnson Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Biopharmaceutical and Vaccine Production Product
Table 89. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Biopharmaceutical and Vaccine Production Product
Table 94. Merck Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Lonza Company Details
Table 97. Lonza Business Overview
Table 98. Lonza Biopharmaceutical and Vaccine Production Product
Table 99. Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 100. Lonza Recent Development
Table 101. FUJIFILM Diosynth Biotechnologies Company Details
Table 102. FUJIFILM Diosynth Biotechnologies Business Overview
Table 103. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product
Table 104. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 105. FUJIFILM Diosynth Biotechnologies Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Biopharmaceutical and Vaccine Production Picture
Figure 2. Global Biopharmaceutical and Vaccine Production Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biopharmaceutical and Vaccine Production Market Share by Type: 2024 VS 2031
Figure 4. Biopharmaceutical Features
Figure 5. Vaccine Production Features
Figure 6. Global Biopharmaceutical and Vaccine Production Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Biopharmaceutical and Vaccine Production Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Case Studies
Figure 9. Biotechnology Case Studies
Figure 10. Academic and Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Biopharmaceutical and Vaccine Production Report Years Considered
Figure 13. Global Biopharmaceutical and Vaccine Production Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Biopharmaceutical and Vaccine Production Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Biopharmaceutical and Vaccine Production Market Share by Region: 2024 VS 2031
Figure 16. Global Biopharmaceutical and Vaccine Production Market Share by Players in 2024
Figure 17. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccine Production Revenue in 2024
Figure 19. North America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Biopharmaceutical and Vaccine Production Market Share by Country (2020-2031)
Figure 21. United States Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biopharmaceutical and Vaccine Production Market Share by Country (2020-2031)
Figure 25. Germany Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biopharmaceutical and Vaccine Production Market Share by Region (2020-2031)
Figure 33. China Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biopharmaceutical and Vaccine Production Market Share by Country (2020-2031)
Figure 41. Mexico Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biopharmaceutical and Vaccine Production Market Share by Country (2020-2031)
Figure 45. Turkey Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 53. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 54. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 55. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 57. Merck Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 58. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 59. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biopharmaceutical
Table 3. Key Players of Vaccine Production
Table 4. Global Biopharmaceutical and Vaccine Production Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Biopharmaceutical and Vaccine Production Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Biopharmaceutical and Vaccine Production Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Biopharmaceutical and Vaccine Production Market Share by Region (2020-2025)
Table 8. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Biopharmaceutical and Vaccine Production Market Share by Region (2026-2031)
Table 10. Biopharmaceutical and Vaccine Production Market Trends
Table 11. Biopharmaceutical and Vaccine Production Market Drivers
Table 12. Biopharmaceutical and Vaccine Production Market Challenges
Table 13. Biopharmaceutical and Vaccine Production Market Restraints
Table 14. Global Biopharmaceutical and Vaccine Production Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Biopharmaceutical and Vaccine Production Market Share by Players (2020-2025)
Table 16. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2024)
Table 17. Ranking of Global Top Biopharmaceutical and Vaccine Production Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Biopharmaceutical and Vaccine Production Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Biopharmaceutical and Vaccine Production, Headquarters and Area Served
Table 20. Global Key Players of Biopharmaceutical and Vaccine Production, Product and Application
Table 21. Global Key Players of Biopharmaceutical and Vaccine Production, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biopharmaceutical and Vaccine Production Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2020-2025)
Table 25. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2026-2031)
Table 27. Global Biopharmaceutical and Vaccine Production Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2020-2025)
Table 29. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2026-2031)
Table 31. North America Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis Biopharmaceutical and Vaccine Production Product
Table 49. Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Pfizer Company Details
Table 52. Pfizer Business Overview
Table 53. Pfizer Biopharmaceutical and Vaccine Production Product
Table 54. Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Sanofi Company Details
Table 57. Sanofi Business Overview
Table 58. Sanofi Biopharmaceutical and Vaccine Production Product
Table 59. Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Biopharmaceutical and Vaccine Production Product
Table 64. Roche Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Biopharmaceutical and Vaccine Production Product
Table 69. Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Regeneron Pharmaceuticals Company Details
Table 72. Regeneron Pharmaceuticals Business Overview
Table 73. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product
Table 74. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 75. Regeneron Pharmaceuticals Recent Development
Table 76. Alexion Pharmaceuticals Company Details
Table 77. Alexion Pharmaceuticals Business Overview
Table 78. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product
Table 79. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 80. Alexion Pharmaceuticals Recent Development
Table 81. Johnson and Johnson Company Details
Table 82. Johnson and Johnson Business Overview
Table 83. Johnson and Johnson Biopharmaceutical and Vaccine Production Product
Table 84. Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 85. Johnson and Johnson Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Biopharmaceutical and Vaccine Production Product
Table 89. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Biopharmaceutical and Vaccine Production Product
Table 94. Merck Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Lonza Company Details
Table 97. Lonza Business Overview
Table 98. Lonza Biopharmaceutical and Vaccine Production Product
Table 99. Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 100. Lonza Recent Development
Table 101. FUJIFILM Diosynth Biotechnologies Company Details
Table 102. FUJIFILM Diosynth Biotechnologies Business Overview
Table 103. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product
Table 104. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2020-2025) & (US$ Million)
Table 105. FUJIFILM Diosynth Biotechnologies Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Biopharmaceutical and Vaccine Production Picture
Figure 2. Global Biopharmaceutical and Vaccine Production Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biopharmaceutical and Vaccine Production Market Share by Type: 2024 VS 2031
Figure 4. Biopharmaceutical Features
Figure 5. Vaccine Production Features
Figure 6. Global Biopharmaceutical and Vaccine Production Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Biopharmaceutical and Vaccine Production Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Case Studies
Figure 9. Biotechnology Case Studies
Figure 10. Academic and Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Biopharmaceutical and Vaccine Production Report Years Considered
Figure 13. Global Biopharmaceutical and Vaccine Production Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Biopharmaceutical and Vaccine Production Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Biopharmaceutical and Vaccine Production Market Share by Region: 2024 VS 2031
Figure 16. Global Biopharmaceutical and Vaccine Production Market Share by Players in 2024
Figure 17. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccine Production Revenue in 2024
Figure 19. North America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Biopharmaceutical and Vaccine Production Market Share by Country (2020-2031)
Figure 21. United States Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biopharmaceutical and Vaccine Production Market Share by Country (2020-2031)
Figure 25. Germany Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biopharmaceutical and Vaccine Production Market Share by Region (2020-2031)
Figure 33. China Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biopharmaceutical and Vaccine Production Market Share by Country (2020-2031)
Figure 41. Mexico Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biopharmaceutical and Vaccine Production Market Share by Country (2020-2031)
Figure 45. Turkey Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Biopharmaceutical and Vaccine Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 53. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 54. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 55. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 57. Merck Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 58. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 59. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232